Esaxerenone Intermediate 1631030-76-6

Esaxerenone Intermediate CAS 1631030-76-6 is an important heterocyclic building block used in the synthetic development of Esaxerenone, a non-steroidal mineralocorticoid receptor antagonist for hypertension treatment. Chemically identified as 1H-Pyrrole-3-carboxylic acid, 4-methyl-5-[2-(trifluoromethyl)phenyl]-, ethyl ester, this compound contains a substituted pyrrole ring and an ethyl ester functional group, providing a valuable structural foundation for subsequent API synthesis.

As an Esaxerenone API Intermediate, its molecular architecture makes it particularly relevant to pharmaceutical processes involving pyrrole construction, functional group transformation, and the assembly of complex heterocyclic drug molecules.

The preparation of this intermediate involves several important organic synthesis stages, with particular attention to pyrrole ring formation and reaction selectivity.

• Precursor Preparation: Suitable aromatic starting materials, including 2-(trifluoromethyl)phenyl derivatives, are selected and processed to obtain the required reactive precursors for subsequent synthesis.

• Pyrrole Ring Construction: A key synthetic approach involves the cyclization of an isocyanide intermediate with ethyl 2-butynoate under suitable basic and metal-catalyzed conditions. This reaction establishes the substituted pyrrole framework.

• Ester Functional Group Formation: The ethyl ester functionality is retained as an important structural feature, allowing further chemical transformations in the downstream synthesis of Esaxerenone.

• Purification and Crystallization: Reaction work-up, impurity removal, and crystallization are optimized to improve product purity, chemical consistency, and batch reproducibility.

• Process Optimization: Reaction selectivity, conversion efficiency, solvent selection, and isolation conditions are evaluated to support a stable and scalable production process.

  
  

The control of regioselectivity and impurity profiles is particularly important when producing pharmaceutical-grade heterocyclic intermediates.

The primary application of Esaxerenone Raw Material CAS 1631030-76-6 is as a key building block in the synthesis of Esaxerenone. Its substituted pyrrole structure provides the foundation for subsequent functionalization, including transformations involved in constructing the final pyrrole-3-carboxamide structure.

For pharmaceutical developers, the quality of this intermediate can influence downstream reaction performance, impurity control, and overall synthesis efficiency. It is therefore relevant to process development, route optimization, and commercial API production.

When evaluating an Esaxerenone Intermediate Manufacturer, pharmaceutical buyers typically consider synthetic route maturity, batch consistency, impurity control, and production scalability. Searches for an Esaxerenone API Intermediate Manufacturer or 1631030-76-6 Manufacturer China should also take into account process reliability and the manufacturer's experience with heterocyclic pharmaceutical intermediates. These factors are essential when selecting a dependable Pharmaceutical Intermediate Manufacturer.

Rocky Pharm provides pharmaceutical raw material sourcing services through established supply channels in China. For customers looking to purchase Esaxerenone Intermediate CAS 1631030-76-6, we can assist with supplier coordination, product availability evaluation, and competitive sourcing options according to specific purchasing requirements.

Whether you are developing an Esaxerenone synthesis route or arranging commercial API production, contact Rocky Pharm for product details, current supply availability, and a competitive quotation.